에 대한 최신 뉴스 MAIA Biotechnology (AMEX:MAIA) 주식

MAIA Biotechnology

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

MAIA Biotechnology Inc

ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) will release its first-quarter earnings results before the <a href="https://www.benzinga.com/quote/ZIM/earnings">opening bell on Monday, May 19.</a>
Analysts expect the Haifa, Israel-based company to report quarterly earnings at $1.96 per share, up from 75 cents per share in the year-ago period. According to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, ZIM Integrated Shipping projects quarterly revenue at $1.84 billion, compared to $1.56 billion a year earlier.
On March 12, ZIM Integrated Shipping reported a fourth-quarter sales increase of 80% year over year to $2.17 billion, beating the consensus of $2.06 billion.
ZIM Integrated Shipping shares fell 1.4% to close at $18.03 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/zim/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Jefferies analyst Omar Nokta maintained a Hold rating and raised the price target from $15 to $16 on May 13, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Citigroup analyst Sathish Sivakumar downgraded the stock from Neutral to Sell and boosted the price target from $11.6 to $13 on June 6, 2024. This analyst has an accuracy rate of 64%.</li>
</ul>
Considering buying ZIM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image is-resized"><img decoding="async" src="blob:https://editorial.benzinga.com/018bec95-6339-41db-ac20-6347b3bea363" alt="" style="width:623px;height:auto" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

Top Wall Street Forecasters Revamp ZIM Integrated Shipping Services Expectations Ahead Of Q1 Earnings

RBC Bearings Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) will release its fourth-quarter earnings results before the <a href="https://www.benzinga.com/quote/RBC/earnings">opening bell on Friday, May 16.</a>
Analysts expect the Oxford, Connecticut-based company to report quarterly earnings at $2.7 per share, up from $2.47 per share in the year-ago period. According to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, RBC Bearings projects quarterly revenue at $440.26 million, compared to $413.68 million a year earlier.
On Jan. 31, RBC Bearings reported better-than-expected third-quarter financial results and issued fourth-quarter net sales guidance above estimates.
RBC Bearings shares gained 0.8% to close at $367.27 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/RBC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Truist Securities analyst Michael Ciarmoli maintained a Buy rating and cut the price target from $410 to $375 on April 17, 2025. This analyst has an accuracy rate of 82%.</li>
<li>Morgan Stanley analyst Kristine Liwag maintained an Overweight rating and boosted the price target from $360 to $390 on Feb. 4, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Keybanc analyst Steve Barger maintained an Overweight rating and raised the price target from $375 to $395 on Feb. 3, 2025. This analyst has an accuracy rate of 73%.</li>
<li>B of A Securities analyst Ronald Epstein downgraded the stock from Buy to Neutral and raised the price target from $330 to $335 on Nov. 21, 2024. This analyst has an accuracy rate of 64%.</li>
<li>Raymond James analyst Tim Thein initiated coverage on the stock with a Market Perform rating on June 28, 2024. This analyst has an accuracy rate of 70%.</li>
</ul>
Considering buying RBC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="571" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190-1024x571.png" alt="" class="wp-image-917522" style="width:593px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190-1024x571.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16025825/image-190.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

RBC Bearings Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

<ul>
<li>Invisalign Palatal Expanders offer doctors a removeable, safe, and clinically effective alternative to traditional palatal expanders.</li>
<li>With Invisalign First&#x2122; aligners and Invisalign&#xAE; Palatal Expanders, Align Technology now provides doctors with a full early intervention treatment solution, including both skeletal (orthopedic) and dental (orthodontic) arch expansion.</li>
</ul>

ALGN

Reported Earlier, Align's Invisalign Palatal Expander System Cleared By NMPA, Set For Commercial Launch In China In Second Half Of 2025

Multinational retailer Walmart Inc.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) e-commerce businesses turned profitable for the first time in the U.S. and globally during the first quarter of the ongoing fiscal year despite looming tariff uncertainties.
What Happened: CEO Doug McMillon expressed optimism over the company&#8217;s e-commerce initiatives during the earnings call and highlighted that it&#8217;s not only serving its customers and members but also making their business more profitable with higher returns over time.
&#8220;We achieved eCommerce profitability, both in the U.S. as well as for the global enterprise in Q1 for the first time, an important milestone for our company,&#8221; he said.
Globally, Walmart&#8217;s e-commerce business grew by 22%, with each segment delivering growth of at least 20%.
The three segments of its e-commerce businesses encompassed growth from Walmart U.S., Walmart International, and its Sam&#8217;s Club U.S. businesses.
&#8220;We&#8217;re encouraged by the fact that eCommerce growth across all three segments continues to be strong, all three segments growing more than 20%,&#8221; added McMillon.
Meanwhile, while addressing the tariff issue, he thanked President Donald Trump and Treasury Secretary Scott Bessent for the progress made recently. He hoped for a longer-term agreement with China amid the ongoing 90-day pause.
However, he added that &#8220;We will do our best to keep our prices as low as possible. But given the magnitude of the tariffs, even at the reduced levels announced this week, we aren&#8217;t able to absorb all the pressure given the reality of narrow retail margins.&#8221;
&#8220;All of the tariffs create cost pressure for us, but the larger tariffs on China have the biggest impact,&#8221; explained McMillon.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/05/45399940/warren-buffett-shows-how-patience-pays-98-of-his-160-billion-wealth-came-after-turning-65-thanks-the-power-of-compound-interest">Warren Buffett Shows How Patience Pays: 98% Of His $160 Billion Wealth Came After Turning 65, Thanks The Power Of &#8216;Compound Interest&#8217;</a>
Why It Matters: Walmart&#8217;s <a href="https://www.benzinga.com/news/earnings/25/05/45436534/walmart-doesnt-alter-annual-outlook-yet-ceo-says-all-tariffs-create-cost-pressures-but-china-has-biggest-impact">first-quarter revenue</a> marginally missed the analyst consensus estimate of $165.88 billion and came in at $165.60 billion, higher by 2.5% year-on-year.
It reported adjusted EPS of 61 cents, beating the consensus estimate of 58 cents.
Walmart anticipates second-quarter fiscal year 2026 sales to increase by 3.5% to 4.5% on a constant currency basis, projecting revenues between $173.67 billion and $175.35 billion. This range falls slightly below the consensus estimate of $175.21 billion.
Shares of WMT fell 0.50% on Thursday. However, the stock was up 7.06% on a year-to-date basis and 50.52% higher over a year.
Benzinga Edge Stock Rankings shows that WMT had a stronger price trend over the short, medium, and long term. Its momentum ranking was solid at the 92.66th percentile, whereas its value ranking was moderate at the 46.64th percentile; the details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>. 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="145" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE-1024x145.png" alt="" class="wp-image-917474" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE-1024x145.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE-300x43.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE-768x109.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16022458/WMT-EDGE.png 1227w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher on Thursday. The SPY was up 0.49% to $590.46, while the QQQ advanced 0.11% to $519.25, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Friday, the futures of the S&amp;P 500, Dow Jones and Nasdaq 100 indices were trading flat. 
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45399783/gordon-johnson-warns-of-potential-liberation-day-20-as-30-year-treasury-yields-approach-5-amid-dollar-weakness">Gordon Johnson Warns Of Potential &#8216;Liberation Day 2.0&#8217; As 30-Year Treasury Yields Approach 5% Amid Dollar Weakness</a></li>
</ul>
image via shutterstock

Earnings Beats

Earnings Misses

Equities

Market Summary

Broad U.S. Equity ETFs

Guidance

Futures

ETFs

General

Walmart E-Commerce Turns Profitable For The First Time: Despite Reduced Tariffs, CEO Says Full Impact Can't Be Absorbed, Price Hikes Likely

Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.&nbsp;

WENN

WENNU

Reported Earlier, Wen Acquisition Corp Launches $261M Initial Public Offering Of 26.1M Units At $10/Unit

Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments.&nbsp;

IPOs

CCCMU

Reported Earlier, Columbus Circle Capital I Launches $220M Initial Public Offering Of 22M Units At $10/Unit

TruGolf Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 125 percent. This is a 59.09 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $5.39 million which missed the analyst consensus estimate of $5.64 million by 4.53 percent. This is a 7.52 percent increase over sales of $5.01 million the same period last year.

TRUG

TruGolf Holdings Q1 EPS $(0.09) Misses $(0.04) Estimate, Sales $5.39M Miss $5.64M Estimate

Reading Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDI#NASDAQ">RDI</a>) reported quarterly losses of $(0.21) per share. This is a 61.11 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $40.20 million which beat the analyst consensus estimate of $38.97 million by 3.17 percent. This is a 10.77 percent decrease over sales of $45.05 million the same period last year.

Reading Intl Q1 EPS $(0.21) Up From $(0.54) YoY, Sales $40.20M Beat $38.97M Estimate

SENS

Reported Earlier, Senseonics Prices $50M Public Offering Of 100M Common Shares At $0.50 Per Share

WeRide Launches Fully Driverless Robotaxi Trials in Abu Dhabi, Expands Service to Al Maryah And Al Reem Islands

Jim Cramer weighed in on the deepening crisis at one of America&#8217;s largest health insurers, which has lately found itself under intense scrutiny by the public, regulators, and the media. 
What Happened: On Thursday, Cramer commented on UnitedHealth Group Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) mounting troubles, zeroing in on the company&#8217;s public denial of a Wall Street Journal report about a federal criminal probe, on his X account.
&#8220;UnitedHealth is denying the WSJ story about them,&#8221; Cramer posted, before calling it &#8220;crucial,&#8221; and adding that &#8220;if convicted of criminal Medicare fraud, well, I don&#8217;t know…&#8221; regarding the stock. The CNBC host&#8217;s remarks reflect the uncertainty now gripping the markets and investors as scrutiny over UnitedHealth intensifies.
See More: <a href="https://www.benzinga.com/markets/options/25/05/45460072/wall-street-getting-nervous-magnificent-7-giants-face-33m-bet-against-them-as-market-turbulence-looms">Wall Street Getting Nervous? Magnificent 7 Giants Face $33M Bet Against Them As Market Turbulence Looms</a>
According <a href="https://www.wsj.com/us-news/unitedhealth-medicare-fraud-investigation-df80667f">to</a> the WSJ report, the Justice Department's criminal healthcare fraud division has been investigating UnitedHealth since at least last summer. The probe reportedly centers on billing practices tied to its Medicare Advantage program.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">United Health is denying the WSJ story about them. Crucial because if convicted of criminal Medicare fraud, well, i don&#39;t know&#8230;
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1923018153350631806?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Besides this, the company is facing a barrage of issues, with several other lawsuits from customers, investors, and regulators, the <a href="https://benzinga.com/content/45375716/stat-unitedhealth-stock-tumbles-as-ceo-resigns-2025-outlook-pulled">abrupt exit of its CEO</a> early this week, and a stock that has lost nearly half its value since April.
Why It Matters: The company <a href="https://www.benzinga.com/general/health-care/25/05/45426769/unitedhealth-stock-plunges-over-8-in-after-hours-trading-as-doj-criminal-probe-adds-to-turmoil-after-ceo-shake-up">pushed back against</a> the report when Benzinga reached out to them on Thursday. Saying that they have &#8220;not been notified of any criminal investigation,&#8221; and that they stand by &#8220;the integrity of our Medicare Advantage business,&#8221; while calling WSJ&#8217;s reporting as &#8220;deeply irresponsible.&#8221;
UnitedHealth Group has faced a string of negative catalysts over the past couple of months, starting with <a href="https://www.benzinga.com/general/health-care/24/12/42316904/unitedhealthcare-ceo-brian-thompson-fatally-shot-outside-nyc-hotel">the assassination</a> of its subsidiary, UnitedHealthcare&#8217;s CEO, Brian Thompson, in December 2024. Since then, the company has faced lawsuits from investors, who claim the company hid the potential impact of this assassination.
Early this month, Cramer <a href="https://benzinga.com/trading-ideas/long-ideas/25/05/45133450/jim-cramer-this-consumer-cyclical-stock-is-a-one-trick-pony">changed his stance</a> on the stock, saying that he would &#8220;indeed start a position&#8221; in the stock at $400 a share after being &#8220;very negative&#8221; on it. The stock has since dropped 31% in the preceding two weeks.
Price Action: Shares of UnitedHealth were down 10.93% on Thursday, despite the company dismissing claims of a federal criminal investigation. It is up 1.29% after hours.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="141" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-1024x141.png" alt="" class="wp-image-917435" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-1024x141.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-300x41.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-768x106.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-1536x212.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM.png 1594w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The stock fares poorly across most metrics in Benzinga&#8217;s Edge Stock Rankings. It&#8217;s competitor Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) does considerably better. You can find out more <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a>.
Photo courtesy: katz / Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/management/25/05/45456642/bill-ackman-loads-up-on-uber-dumps-nike-in-major-q1-portfolio-rebalance">Bill Ackman Loads Up On Uber In Major Q1 Portfolio Rebalance (CORRECTED)</a></li>
</ul>

Government

Health Care

Jim Cramer Reacts As UnitedHealth Denies  Report On Criminal Probe—'If Convicted of Criminal Medicare Fraud…'

Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) executive chairman, Michael Saylor, says the company, formerly known as MicroStrategy, could survive a brutal crypto winter, but its shareholders wouldn&#8217;t be too happy about it.
What Happened: In a new Financial Times <a href="https://www.ft.com/video/4d1a1666-20d4-4930-ab80-eda742640f16">film</a> and subsequent interviews, Saylor warned that if Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) "fell 90 per cent and stayed there for four or five years, we would still be stable," yet equity investors "would suffer because they're levered."
The alert comes as MicroStrategy — already the world's largest corporate holder of the token at <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45349057/strategy-buys-134b-in-bitcoin-at-99856-cites-155-btc-yield">568,840 BTC</a> worth about $59 billion — keeps piling on debt and preferred-stock financings to buy more.
Saylor's endgame is simple. "Whoever gets the most bitcoin wins. There is no other endgame," he told Yahoo Finance in a separate <a href="https://finance.yahoo.com/news/michael-saylor-is-never-selling-microstrategys-bitcoin-100028211.html?guccounter=1&amp;guce_referrer=aHR0cHM6Ly9mb3J0dW5lLmNvbS8&amp;guce_referrer_sig=AQAAAA0_cDmg_yzUnWkCMGRMws58uA4m5pNkrk4-fuSqVHXxJeAqApmq-qjKyHiettjO_4mfIipQjgHmdG2p97lFQnQfbvQQg0dLC4Tgwo-eU1W42llt5dsynyG1hJipd6xQTyFtZKKAI45R8vcaavU9Jl8y8caZOu2-ZCAa2-MKJf6W">sit-down</a>. To keep buying, MicroStrategy sold $580 million of dividend-paying <a href="https://www.barrons.com/articles/microstrategy-preferred-stock-yield-bb1b45ef">preferred shares</a> in January and another perpetual-preferred slug in March — cash it can deploy straight into crypto.
The balance sheet now holds just $60.3 million in cash against tens of billions in digital assets, its latest 10-Q shows. Former Bank of America ECM chief Craig Coben tells FT that Strategy&#8217;s focus on "new money" raises "questions about the sustainability" of the bet if prices crater.
See also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45417306/michael-saylors-bitcoin-strategy-infinite-money-glitch-or-a-reflexive-leverage-bet">Michael Saylor&#8217;s Bitcoin Strategy—&#8217;Infinite Money Glitch&#8217; Or A Reflexive Leverage Bet?</a>
Saylor shrugs at the skeptics, even <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44044388/michael-saylor-says-sell-a-kidney-but-keep-the-bitcoin-but-mstr-is-down-28-since-he-appeared-on-the-cover-of-forbes">trolling them</a> on X: "Sell a kidney if you must, but keep the Bitcoin." But Saylor's own warning shows just how thin the ice could get if the next crypto winter proves deeper and longer than the last.
Top 3 Bitcoin-Holding Public Companies
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Company Name</td>
<td>Amount Of BTC Held</td>
<td>Value In U.S. Dollars</td>
</tr>
<tr>
<td>MicroStrategy</td>
<td>568,840 BTC</td>
<td>59.16 billion</td>
</tr>
<tr>
<td>Marathon Digital</td>
<td>46,374 BTC</td>
<td>4.82 billion</td>
</tr>
<tr>
<td>Riot Platforms</td>
<td>18,692 BTC</td>
<td>1.94 billion</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: Coingecko.</figcaption></figure>
Why It Matters: Economist Peter Schiff, a fierce critic of all things Bitcoin, has consistently questioned Strategy's Bitcoin playbook, recently predicted &#8220;<a href="https://www.benzinga.com/markets/25/05/45426766/peter-schiff-predicts-fireworks-says-michael-saylors-strategy-will-see-unrealized-loss-during-bitcoi">fireworks</a>&#8221; if Bitcoin were to drop in value. Schiff stated that a significant BTC slump could soon even push MSTR "into the red."
That said, JPMorgan analysts expect <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45444794/bitcoin-is-starting-to-outperform-gold-jpmorgan">continued Bitcoin upside</a> into late 2025, driven by sector-specific momentum and weakening gold sentiment. Major U.S. exchanges like Coinbase, Kraken, and Gemini are expanding regulated crypto derivatives offerings to institutional investors, all adding to the crypto king&#8217;s momentum.
Price Action: Shares of MicroStrategy closed 4.73% lower at $397.03 on Thursday. The stock has gained 32.34% since the beginning of 2025, <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">according to data from Benzinga Pro</a>.
Benzinga Edge Stock Rankings indicate that Strategy has a Momentum in the 97th percentile. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-3/?adType=quotepage&amp;campaign=ranking&amp;ad=rankingv1">Click here</a> to see how rivals like Coinbase stack up in comparison.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-3/?adType=quotepage&amp;campaign=ranking&amp;ad=rankingv1"><img loading="lazy" decoding="async" width="1024" height="148" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-1024x148.png" alt="" class="wp-image-917437" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-1024x148.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-300x43.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-768x111.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge-1536x222.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013122/mstr-edge.png 1620w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Photo Courtesy: Bukhta Yurii On Shutterstock.com
Read next: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45449661/eric-trump-bitcoin-accumulation-is-a-race-to-the-top">Eric Trump: Bitcoin Accumulation Is &#8216;A Race To The Top&#8217;</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MARA

MSTR

RIOT

Michael Saylor Says Strategy Inc. Shareholders Could 'Suffer' If Bitcoin Plunges 90% For Half A Decade, But Reveals A Winning Endgame

&#8216;The Big Short&#8217; famed investor Michael Burry, who accurately predicted the 2008 housing market crash, has turned bearish on most equities while doubling his stake in cosmetics giant Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) during the first quarter, according to 13F regulatory filings with the Securities and Exchange Commission on Thursday.
What Happened: Burry&#8217;s Scion Asset Management increased its position in Estée Lauder to 200,000 shares from 100,000 shares at the end of the fourth quarter, despite EL stock being down 13.94% this year. The move comes as the beauty company pursues its &#8220;Beauty Reimagined&#8221; <a href="https://www.benzinga.com/25/05/45179419/estee-lauders-beauty-gains-cant-offset-global-headwinds-says-analyst">recovery strategy amid global headwinds</a>.
EL stock closed at $63.67 on Thursday, down 0.69% for the day. In after-hours trading, the stock rose 3.85% to $66.12, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
The 13F report revealed significant portfolio adjustments, including Scion taking a substantial bearish position on artificial intelligence leader NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) through 900,000 put options. NVIDIA shares have retreated from their January all-time high of $153.13 amid macroeconomic concerns and worries about tariff impacts.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45460177/bitcoin-rises-while-ethereum-dogecoin-slip-market-isnt-going-to-peak-in-the-next-6-months-says-popular-analyst">Bitcoin Rises While Ethereum, Dogecoin Slip — &#8216;Market Isn&#8217;t Going To Peak In The Next 6 Months,&#8217; Says Popular Analyst</a>
Why It Matters: Burry also completely liquidated his positions in Chinese tech companies, including Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), Baidu Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), JD.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), and PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>). 
This exit coincides with President Donald Trump&#8216;s April announcement of hefty import tariffs targeting China, though both nations recently agreed to <a href="https://www.benzinga.com/25/04/44946516/goldman-sachs-ceo-says-trumps-90-day-tariff-pause-increased-the-level-of-uncertainty-triggered-market-repricing">suspend reciprocal levies for 90 days</a>.
The hedge fund manager also exited healthcare positions in HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), Oscar Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>), and Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>).
Analysts note that while Estée Lauder delivered <a href="https://www.benzinga.com/25/05/45179419/estee-lauders-beauty-gains-cant-offset-global-headwinds-says-analyst">stronger-than-expected third quarter earnings</a> with improved margins and cost control, the company still faces challenges, particularly in Asia travel retail and a softening North American market.
Photo Courtesy: Sorbis On Shutterstock.com
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45459474/sounds-familiar-mohamed-el-erian-calls-out-powells-deja-vu-on-supply-shocks-economist-draws-historic-parallels-on-fed-chairs-latest-message">&#8216;Sounds Familiar?&#8217; Mohamed El-Erian Calls Out Powell&#8217;s Déjà Vu On Supply Shocks—Economist Draws Historic Parallels On Fed Chair&#8217;s Latest Message</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

BABA

BIDU

NVDA

OSCR

Citigourp Global Markets 2% Protected Notes Linked To The Djia

'The Big Short' Fame Michael Burry Doubled Estée Lauder Stake Despite Slump, Bet Against Nvidia And Dumps China Stocks Amid Trade War Jitters In Q1

Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is reportedly expanding its research footprint in China with a new Shanghai-based R&amp;D center, signaling a strategic push to retain AI dominance in the region amid tightening U.S. export restrictions.
What Happened: Nvidia CEO Jensen Huang met with Shanghai Mayor Gong Zheng last month to discuss plans for the new facility, <a href="https://www.ft.com/content/c886a4c0-da75-4ea7-8230-6ffd18815fa4">reported</a> the Financial Times, citing two people with knowledge of the matter.
Nvidia is already leasing new office space in Shanghai to house current staff and accommodate the expansion.
While the company said that no GPU designs will be sent to China, the R&amp;D center will focus on optimizing existing products, verifying chip designs and exploring use cases like autonomous driving, the report noted.
See Also:&nbsp;<a href="https://www.benzinga.com/tech/25/05/45309175/nvidia-modifies-h20-chip-for-china-after-us-restrictions-block-sales-aims-to-deliver-new-version-by-july-report" target="_blank" rel="noreferrer noopener">Nvidia Modifies H20 Chip For China After US Restrictions Block Sales, Aims To Deliver New Version By July: Report</a>
"We are not sending any GPU designs to China to be modified to comply with export controls," Nvidia told the publication.
Why It's Important: The move underscores <a href="https://www.benzinga.com/25/04/44963176/chinese-tech-firms-led-by-alibaba-hoard-nvidia-ai-chips-amid-us-sanctions">Nvidia's delicate balancing act</a>—maintaining a presence in one of its largest overseas markets while adhering to U.S. export controls.
China accounted for roughly 14% of Nvidia's revenue in 2023, or about $17 billion. Huang has said the market could be worth as much as $50 billion.
Huang previously warned that limiting access to <a href="https://www.benzinga.com/markets/25/05/45243129/nvidia-ceo-jensen-huang-says-losing-access-to-chinas-potential-50-billion-ai-market-would-be-a-tremendous-loss">China's AI market could harm</a> not only Nvidia's business but also U.S. jobs and technological progress.
His remarks followed reports that Nvidia had notified major Chinese customers — including Alibaba Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), ByteDance and Tencent Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCEHY#OTC">TCEHY</a>) — that it is developing a <a href="https://www.benzinga.com/25/05/45182565/nvidia-designing-new-ai-chips-for-alibaba-bytedance-tencent-after-warning-us-export-ban-on-h20-could-cost-the-company-55-billion-report">modified version of AI chips</a> to meet U.S. export restrictions.
Price Action: Nvidia shares slipped 0.096% to $134.70 in after-hours trading, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
According to Benzinga Edge Stock Rankings, Nvidia currently holds a growth score of 95.06%. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Click here to see how it stacks up against top tech firms like</a> AMD, Qualcomm, Alibaba and Tencent.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/NVDA"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16012658/Screenshot-2025-05-16-at-10.56.52%E2%80%AFAM.png" alt="" class="wp-image-917430" /></a></figure>
Photo Courtesy: Hepha1st0s On Shutterstock.com
Read Next:
<ul class="wp-block-list">
<li><a href="https://benzinga.com/25/04/45071155/mild-recession-is-best-case-outcome-jpmorgan-ceo-jamie-dimon" target="_blank" rel="noreferrer noopener">JPMorgan CEO Jamie Dimon Warns Recession Is Best-Case Outcome Of Trump Trade War</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

Media

TCEHY

Jensen Huang-Led Nvidia Plans New Shanghai Research Hub To Stay Competitive In China As US Export Curbs Threaten AI Chip Sales: Report

Macro Economic Events

Econ #s

Economics

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, Japan Gross Domestic Product Price Index (YoY) Preliminary For Q1 3.2% Vs. 3.2% Est.; 2.9% Prior

Reported Earlier, Japan Gross Domestic Product (YoY) Preliminary For Q1 -0.7% Vs. -0.2% Est.; 2.4% (Revised) Prior

Reported Earlier, Japan Gross Domestic Product (QoQ) Preliminary For Q1 -0.2% Vs. -0.1% Est.; 0.6% Prior

Japan Industrial Production (MoM) For March: 0.2% Vs. -1.1% Est.; 2.3% Prior

Editor&#8217;s Note: This article has been updated to reflect that Pershing Square converted its Nike stock into call options, maintaining exposure
Bill Ackman could have a new love for the automotive sector with a new investment made in the first quarter and an added position to a stake from the fourth quarter of 2024 that was <a href="https://www.benzinga.com/25/04/44878275/billionare-investor-bill-ackman-posts-hertz-investment-thesis-proposes-av-fleet-partnership-with-uber">revealed in April.</a>
Here's a look at Ackman's investment holdings in Pershing Square as of March 31.
First Quarter Changes: Ackman and Pershing Square unveiled a new stake in Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) in the first quarter with a position of more than 30 million shares. The stake is now the largest holding the Pershing Square portfolio and comes with the investor making several recent moves to his investment strategy.
Ackman increased his stake in Hertz Global Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) in the first quarter with the <a href="https://www.sec.gov/Archives/edgar/data/1336528/000117266125002315/0001172661-25-002315-index.html">filing </a>showing an 18% increase.
Ackman's stake in Hertz was unveiled via a tweet and an updated SEC filing in April. A 12.7 million share purchase was originally kept from the fourth-quarter holdings document due to a request for confidentiality.
Here were the other increased stakes in the quarter:
<ul class="wp-block-list">
<li>Brookfield Corporation: +18%</li>
<li>Alphabet Inc Class A (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>): +11%</li>
</ul>
Pershing Square lowered its investments in the following stocks in the first quarter:
<ul class="wp-block-list">
<li>Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>): -45%</li>
<li>Google Class C (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>): -16%</li>
<li>Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>): -13%</li>
<li>Canadian Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>): decreased by less than 1%</li>
</ul>
One notable move in the quarter was Pershing Square&#8217;s conversion of its 18.8 million Nike shares into over-the-counter call options, maintaining a similar economic exposure.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43799342/bill-ackman-following-warren-buffett-hedge-funder-promises-modern-day-berkshire-hathaway-with-latest-transaction">Bill Ackman Follows Warren Buffett: Hedge Funder Promises &#8216;Modern Day Berkshire Hathaway&#8217; With Latest Transaction</a>
Ackman's Top Holdings: The newest 13F filing shows 11 stocks owned by Ackman and Pershing Square. Here are the current holdings and their percentage of the investment fund:
<ul class="wp-block-list">
<li>Uber: 19%</li>
<li>Brookfield: 18%</li>
<li>Restaurant Brands International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>): 13%</li>
<li>Howard Hughes Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HHH#NYSE">HHH</a>): 12%</li>
<li>Chipotle: 9.1%</li>
<li>Canadian Pacific: 8.7%</li>
<li>Alphabet Class C: 8.3%</li>
<li>Alphabet Class A: 5.8%</li>
<li>Hilton: 5.7%</li>
<li>Seaport Entertainment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEG#NYSE">SEG</a>): 0.9%</li>
<li>Hertz: 0.5%</li>
</ul>
The latest 13F filing comes as Ackman is trying to <a href="https://www.benzinga.com/25/05/45401638/howard-hughes-rises-nearly-3-in-pre-market-as-bill-ackman-exits-from-universal-music-groups-board-to-prioritize-new-investments">buy control of </a>Howard Hughes and turn it into a diversified holding company to copy the conglomerate style of legendary investor Warren Buffett.
The Pershing Square 13F could look significantly different next quarter.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/03/44330386/bill-ackman-sells-portion-of-universal-music-stake-one-of-the-best-businesses-we-have-ever-owned">Bill Ackman Sells Portion Of Universal Music Stake: &#8216;One Of The Best Businesses We Have Ever Owned&#8217;</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Management

GOOG

GOOGL

UBER

Bill Ackman Loads Up On Uber In Major Q1 Portfolio Rebalance (CORRECTED)

The world&#8217;s largest cryptocurrency continues to dominate the market, representing 62.2% of the total crypto market capitalization, which currently stands at $3.33 trillion. 
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 11.30 p.m. ET)</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>+1.30%</td>
<td>$104,232</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>-0.47%</td>
<td>$2,577</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>-3.15%</td>
<td>$0.2266</td>
</tr>
</tbody>
</table>
</figure>
Bitcoin&#8217;s dominance increased by 0.74% over the last day, while Ethereum&#8217;s share declined to 9.3%.
Federal Reserve Chair Jerome Powell signaled on Thursday that the central bank is<a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45439079/powell-signals-fed-may-shift-its-inflation-strategy-after-5-year-economic-shake-up"> reassessing its approach to inflation</a> and employment as part of a major policy review.
The CMC Crypto Fear and Greed Index currently registers a score of 69, indicating &#8220;Greed&#8221; in the market. This represents a slight decrease from yesterday&#8217;s reading of 71 but remains elevated compared to last month&#8217;s score of 29, which signaled &#8220;Fear,&#8221; according to data from CoinMarketCap. 
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45450026/bitcoin-holding-up-while-ethereum-xrp-dogecoin-dip-dont-get-distracted-by-short-term-noise-trader-says">Bitcoin Holding Up While Ethereum, XRP, Dogecoin Dip: &#8216;Don&#8217;t Get Distracted By Short Term Noise,&#8217; Trader Says</a>
Meanwhile, traditional markets show modest gains, with S&amp;P 500 futures up 0.0042% at 5,933.50, Nasdaq-100 futures gaining 0.020% to 21,404.50, and Dow Jones Industrial Average futures rising 0.026% to 42,396.00.
In other markets, gold has retreated to around $3,220 per ounce on Friday, heading for a weekly loss exceeding 3% as easing global trade tensions between the U.S. and China reduce its safe-haven appeal.
Top Gainers (24-Hours)
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 11.30 p.m. ET)</td>
</tr>
<tr>
<td>Hyperliquid (HYPE)</td>
<td>+7.87%</td>
<td>$26.97</td>
</tr>
<tr>
<td>Bitget Token (BGB)</td>
<td>+7.03%&nbsp;</td>
<td>$5.06</td>
</tr>
<tr>
<td>Story (IP)</td>
<td>+5.94%</td>
<td>$4.88</td>
</tr>
</tbody>
</table>
</figure>
Analyst Notes:&nbsp;&#8220;Bitcoin has seen some resistance over the past week, being challenged to grow past the $104K to $105K level,&#8221; a crypto market intelligence platform, Santiment, noted on Thursday. &#8220;This temporary &#8216;pumping of the brakes&#8217; has been enough to swing traders slightly bearish once again.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f911; Bitcoin has seen some resistance over the past week, being challenged to grow past the $104K to $105K level. This temporary &quot;pumping of the brakes&quot; has been enough to swing traders slightly bearish once again. Markets generally tend to move opposite to crowd&#39;s expectations,… <a href="https://t.co/7toBDE5y6f">pic.twitter.com/7toBDE5y6f</a>
&mdash; Santiment (@santimentfeed) <a href="https://twitter.com/santimentfeed/status/1923078207491727535?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Despite this short-term resistance, analyst Michaël van de Poppe believes the bull market has significant room to run. &#8220;This market isn&#8217;t going to peak in the next 6 months if we just managed to have a 4-year bear market on Altcoins coming to an end,&#8221; Martinez wrote on social platform X. 
&#8220;The previous bear market was 2 years, and had 2 years of bull since. The 4-year cycle doesn&#8217;t exist anymore,&#8221; van de Poppe added.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This market isn&#39;t going to peak in the next 6 months if we just managed to have a 4-year bear market on <a href="https://twitter.com/hashtag/Altcoins?src=hash&amp;ref_src=twsrc%5Etfw">#Altcoins</a> coming to an end. The previous bear market was 2 years, and had 2 years of bull since. The 4-year cycle doesn&#39;t exist anymore.
&mdash; Michaël van de Poppe (@CryptoMichNL) <a href="https://twitter.com/CryptoMichNL/status/1923120452307910713?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Photo Courtesy: Yalcin Sonat On Shutterstock.com
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/management/25/05/45455434/warren-buffett-ditches-bitcoin-linked-nu-holdings-adds-to-constellation-brands-dominos-pizza-pool-corp-stakes">Warren Buffett Ditches Bitcoin-Linked Nu Holdings, Adds To Constellation Brands, Domino&#8217;s Pizza, Pool Corp Stakes</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

$DOGE

$ETH

Bitcoin Rises While Ethereum, Dogecoin Slip — 'Market Isn't Going To Peak In The Next 6 Months,' Says Popular Analyst

Press Releases

MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer

MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients

MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO

MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug

MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025

MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders

MAIA Biotechnology Announces $1.08 Million Private Placement

CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement

MAIA Biotechnology Announces Director Participation in Recent Private Placement

MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

MAIA

Adicet Bio

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

bluebird bio

Biomea Fusion

Celularity

Cue Biopharma

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Fortress Biotech

Forte Biosciences

Gain Therapeutics

Immix Biopharma

Immuneering Corporation - Class A Common Stock

Immuneering

Metagenomi

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

OKYO Pharma

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

PepGen

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Renovaro

Rein Therapeutics

Repare Therapeutics

Serina Therapeutics

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

Noble Capital Markets

Screenshot 2024-09-10 at 8.49.39 PM

Biotech

REGN

MAIA Biotechnology&#39;s Phase 2 Study Of THIO In Non-Small Cell Lung Cancer Shows Positive Interim Survival Benefits

Screenshot 2024-06-06 at 5.43.20 PM

New Clinical Data Reveals MAIA Biotechnology&#39;s THIO Achieves High Efficacy In Advanced Non-Small Cell Lung Cancer Treatment

Screenshot 2024-05-21 at 5.35.44 PM

MAIA Biotechnology&#39;s Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market

Screenshot 2024-02-28 at 6.41.05 PM

MAIA Biotech Completes Enrollment For Phase 2 Trial Of Its Candidate THIO To Fight Non-Small Cell Lung Cancer

Comments

MAIA Biotechnology

뉴스

에 대한 최신 뉴스 MAIA Biotechnology (AMEX:MAIA) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌